Accumulating evidence suggest that de-coupling ErbB4–PSD-95–NMDA receptor interaction due to mutation or/and reduced expression of any of the member component may represent a key molecular signature of psychiatric episodes, cognitive disorders [29] and altered long-term potentiation (LTP). This evidence concerns the gene ERBB4 and Cognitive impairment.